netFormulary NHS
South Staffordshire Joint Formulary
Cannock Chase Clinical Commissioning Group
East Staffordshire Clinical Commissioning Group
South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group
Stafford and Surrounds Clinical Commissioning Group
 Search
 Formulary Chapter 4: Central nervous system - Full Chapter
04.09.01  Expand sub section  Dopaminergic drugs used in Parkinsons disease
04.09.01  Expand sub section  Dopamine receptor agonists
Apomorphine
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber E

Apomorphine HCl Injection 10mg/ml 2ml Amp

Supported by ESCA only where agreed from initiating trust 

 
   
Pramipexole
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber

pramipexole 0.088 mg tablets
pramipexole 0.18 mg tablets
pramipexole0.35 mg tablets
pramipexole 0.7 mg tablets
 

 
   
Pramipexole modified release tablets (Pipexus®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
Pipexus 0.26 mg prolonged-release tablets
Pipexus 0.52 mg prolonged-release tablets
Pipexus 1.05 mg prolonged-release tablets
Pipexus 1.57 mg prolonged-release tablets
Pipexus 2.10 mg prolonged-release tablets
Pipexus 2.62 mg prolonged-release tablets
Pipexus 3.15 mg prolonged-release tablets

Please prescribe Pramipexole MR as most cost effective brand in primary care Pipexus ®  
   
Ropinirole
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber

Restriction: Initiation and stabilisation by specialist

Ropinirole HCl Tab 250mcg
Ropinirole HCl Tab 500mcg
Ropinirole HCl Tab 1mg
Ropinirole HCl Tab 2mg
Ropinirole HCl Tab 5mg

Ropinirole HCl Tab 2mg M/R 
Ropinirole HCl Tab 3mg M/R  
Ropinirole HCl Tab 4mg M/R
Ropinirole HCl Tab 6mg M/R  
Ropinirole HCl Tab 8mg M/R
 
Ipinnia XL or Repinex XL are the preferred cost-effective MR brands (Applicable in primary care).

 
   
04.09.01  Expand sub section  Levodopa
04.09.01  Expand sub section  Monoamine-oxidase-B inhibitors
04.09.01  Expand sub section  Catachol-O-methyltransferase inhibitors to top
 ....
 Non Formulary Items
Bromocriptine

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Cabergoline  (Cabaser®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Lisuride

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Pergolide  (Celance®)

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary non formulary- NICE states rarely used now due to fibrotic reactions for which there has been a MHRA safety warning
 
Rotigotine

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Drugs which require special consideration. These are drugs for Consultant Prescribing ONLY. They should not be prescribed in Primary Care.  

Amber

Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care. For some drugs there may be a Ricad in place to aid the transition to primary care.  

Amber E

Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care but also require and ESCA (Shared Care Agreement)   

Green

Suitable first-line drugs for implementation in Primary Care  

On Formulary

South Staffs Formulary Choice  

netFormulary